The clinical development services provider Phesi is looking to patent its method and system for developing clinical trial protocols – which enables faster patient enrollment and study completion, says CEO.
Takeda to move US base to Boston
from in-PharmaTechnologist.com
Hired and Retired: Big pharma to biotech trend continues
from BioPharma-Reporter.com
Partnership to provide oncology portfolio with a translational platform
from BioPharma-Reporter.com
‘Unmerited’ hep C patent contributes to Gilead monopoly, says NGO
from in-PharmaTechnologist.com
Could real world evidence replace controlled experiment data?
Clinical evolution
Roche looks beyond clinical trial data to ‘transform oncology’
Clinical evolution
Conflict of interest: Clinical trial authors not fully disclosing financial relationships with sponsors
Transparency on trial
The top 3 myths of ‘going digital’ (and the realities)
Clinical evolution
